| Basic and Diluted Loss per Share (Details) - $ / shares | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 | 
|---|---|---|---|
| Basic and Diluted Loss per Share [Line Items] | |||
| Number of Options, Outstanding balance | 87,041 | 87,764 | |
| Average exercise price (in Dollars per share) | $ 3.53 | $ 3.63 | |
| Convertible shares outstanding | 3,008,641 | 1,737,986 | |
| Restricted Stock Units [Member] | |||
| Basic and Diluted Loss per Share [Line Items] | |||
| RSU’s to purchase shaes | 68,648 | 71,280 | 58,000 | 
| Average grant date fair value (in Dollars per share) | $ 11.33 | $ 10.35 | $ 16.2 | 
| Stock Option [Member] | |||
| Basic and Diluted Loss per Share [Line Items] | |||
| Number of Options, Outstanding balance | 87,041 | 96,023 | |
| Average exercise price (in Dollars per share) | $ 3.52 | $ 4.7 | |
| Convertible Common Stock [Member] | Warrant [Member] | |||
| Basic and Diluted Loss per Share [Line Items] | |||
| Convertible shares outstanding | 2,462,759 | 36,792 | 
| X | ||||||||||
| 
- Definition Number of shares of other common stock instruments held by shareholder, including, but not limited to, exchangeable shares. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 |